Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG vaccine for prevention of COVID-19 in healthcare workers
IRCT20200411047019N1Phase 3Completed
- Sponsor
- Professor Alborzi Clinical Microbiology Research Center
- Start
- Jun 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of bcg vaccine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Professor Alborzi Clinical Microbiology Research Center. Primary endpoints: Confirmed COVID-19 infection, Hospitalization due to COVID-19 and 1 more. Started Jun 2020; status: completed.
02
Drugs
bcg vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200411047019N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200411047019N1.